US Stock Insider Trading | MapLight Therapeutics disclosed two insider trades on February 4

robot
Abstract generation in progress

On February 4, 2026, MapLight Therapeutics (MPLT) disclosed two insider transactions. Director Malenka Robert C. sold 7,039 shares on February 3, 2026.

【Recent Insider Transactions】

Disclosure Date Position Name Transaction Date Buy/Sell Quantity Price per Share/USD Total Amount/USD
February 4, 2026 Director Malenka Robert C. February 3, 2026 Sell 1 18.00 18.00
February 4, 2026 Director Malenka Robert C. February 2, 2026 Sell 7039 18.02 $126,800
January 30, 2026 Director Malenka Robert C. January 30, 2026 Sell 6612 18.11 $119,700
January 30, 2026 Director Malenka Robert C. January 29, 2026 Sell 21,300 18.55 $394,400
January 30, 2026 Director Malenka Robert C. January 28, 2026 Sell 5,860 18.61 $109,100
January 30, 2026 Director Malenka Robert C. January 28, 2026 Sell 664 19.05 $12,600
January 29, 2026 Executive Hanson Kristopher January 27, 2026 Sell 26,000 17.98 $467,600
January 29, 2026 Executive Lillie James Woodruff January 27, 2026 Sell 45,100 17.98 $810,100
January 29, 2026 Director Kroeger Christopher A. January 27, 2026 Sell 204,100 17.98 $3,670,500
January 29, 2026 Executive GILLIS JONATHAN January 27, 2026 Sell 21,100 17.98 $396,500

【Company Information】

MapLight Therapeutics, Inc. was incorporated in November 2018 under Delaware law. The company is a clinical-stage biopharmaceutical company focused on improving the lives of patients with degenerative central nervous system (CNS) diseases. The company aims to address the lack of targeted drug therapies for specific neural circuits in patients. Its discovery platform is designed to identify causal neural circuits related to disease and to develop therapeutic modulation of these circuits. Its lead candidate, ML-007C-MA, is a fixed-dose combination intended to treat psychosis caused by schizophrenia and Alzheimer’s disease, aiming to activate specific muscarinic receptors in the central nervous system while minimizing peripheral side effects.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)